Bluejay Diagnostics Stock Price Prediction
| BJDX Stock | USD 3.50 0.02 0.57% |
Oversold Vs Overbought
37
Oversold | Overbought |
Wall Street Target Price 256 |
Using Bluejay Diagnostics hype-based prediction, you can estimate the value of Bluejay Diagnostics from the perspective of Bluejay Diagnostics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Bluejay Diagnostics to buy its stock at a price that has no basis in reality. In that case, they are not buying Bluejay because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Bluejay Diagnostics after-hype prediction price | USD 5.21 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Bluejay |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bluejay Diagnostics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bluejay Diagnostics After-Hype Price Prediction Density Analysis
As far as predicting the price of Bluejay Diagnostics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Bluejay Diagnostics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Bluejay Diagnostics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Bluejay Diagnostics Estimiated After-Hype Price Volatility
In the context of predicting Bluejay Diagnostics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Bluejay Diagnostics' historical news coverage. Bluejay Diagnostics' after-hype downside and upside margins for the prediction period are 0.26 and 18.76, respectively. We have considered Bluejay Diagnostics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Bluejay Diagnostics is extremely dangerous at this time. Analysis and calculation of next after-hype price of Bluejay Diagnostics is based on 3 months time horizon.
Bluejay Diagnostics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Bluejay Diagnostics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bluejay Diagnostics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Bluejay Diagnostics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.58 | 13.55 | 1.83 | 0.06 | 3 Events / Month | 5 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
3.50 | 5.06 | 44.66 |
|
Bluejay Diagnostics Hype Timeline
Bluejay Diagnostics is currently traded for 3.50. The entity has historical hype elasticity of 1.83, and average elasticity to hype of competition of 0.06. Bluejay is forecasted to increase in value after the next headline, with the price projected to jump to 5.063 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 44.66%, whereas the daily expected return is currently at -0.58%. The volatility of related hype on Bluejay Diagnostics is about 12195.0%, with the expected price after the next announcement by competition of 3.56. Bluejay Diagnostics currently holds 352.98 K in liabilities with Debt to Equity (D/E) ratio of 0.04, which may suggest the company is not taking enough advantage from borrowing. Bluejay Diagnostics has a current ratio of 17.06, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Bluejay Diagnostics' use of debt, we should always consider it together with its cash and equity.Given the investment horizon of 90 days the next forecasted press release will be in about 3 days. Check out Bluejay Diagnostics Basic Forecasting Models to cross-verify your projections.Bluejay Diagnostics Related Hype Analysis
Having access to credible news sources related to Bluejay Diagnostics' direct competition is more important than ever and may enhance your ability to predict Bluejay Diagnostics' future price movements. Getting to know how Bluejay Diagnostics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Bluejay Diagnostics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BBLG | Bone Biologics Corp | (0.13) | 2 per month | 8.77 | 0.04 | 18.13 | (17.14) | 163.17 | |
| TLIS | Talis Biomedical Corp | 0.00 | 0 per month | 0.00 | (0.19) | 5.32 | (10.69) | 68.77 | |
| NUWE | Nuwellis | 0.58 | 6 per month | 10.80 | 0.07 | 25.66 | (20.93) | 141.14 | |
| HSCS | Heart Test Laboratories | 0.33 | 3 per month | 5.33 | 0.0002 | 11.44 | (8.97) | 58.33 | |
| TIVC | Tivic Health Systems | (0.01) | 7 per month | 0.00 | (0.02) | 12.12 | (6.90) | 79.31 | |
| NXL | Nexalin Technology | (0.36) | 9 per month | 6.61 | 0.23 | 25.71 | (12.22) | 71.17 | |
| INVO | INVO Bioscience | 0.57 | 3 per month | 4.69 | 0.02 | 6.67 | (6.85) | 105.62 | |
| MOTS | Motus GI Holdings | 0.00 | 0 per month | 0.00 | (0.05) | 9.09 | (5.63) | 56.89 | |
| IRIX | IRIDEX | 0.02 | 9 per month | 0.00 | (0.03) | 4.76 | (5.33) | 40.39 |
Bluejay Diagnostics Additional Predictive Modules
Most predictive techniques to examine Bluejay price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bluejay using various technical indicators. When you analyze Bluejay charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Bluejay Diagnostics Predictive Indicators
The successful prediction of Bluejay Diagnostics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Bluejay Diagnostics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Bluejay Diagnostics based on analysis of Bluejay Diagnostics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Bluejay Diagnostics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Bluejay Diagnostics's related companies. | 2023 | 2024 (projected) | Payables Turnover | 1.59 | 1.69 | Days Of Inventory On Hand | 226.56 | 281.78 |
Story Coverage note for Bluejay Diagnostics
The number of cover stories for Bluejay Diagnostics depends on current market conditions and Bluejay Diagnostics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Bluejay Diagnostics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Bluejay Diagnostics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Bluejay Diagnostics Short Properties
Bluejay Diagnostics' future price predictability will typically decrease when Bluejay Diagnostics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Bluejay Diagnostics often depends not only on the future outlook of the potential Bluejay Diagnostics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bluejay Diagnostics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 137.1 K | |
| Cash And Short Term Investments | 2.2 M |
Additional Tools for Bluejay Stock Analysis
When running Bluejay Diagnostics' price analysis, check to measure Bluejay Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bluejay Diagnostics is operating at the current time. Most of Bluejay Diagnostics' value examination focuses on studying past and present price action to predict the probability of Bluejay Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bluejay Diagnostics' price. Additionally, you may evaluate how the addition of Bluejay Diagnostics to your portfolios can decrease your overall portfolio volatility.